Clogestone acetate

The experiments, using a total of 1833 Cashmere does, were conducted to examine the effects on fertility and fecundity of intravaginal treatment for control of ovulation, time of insemination by cervical and laparoscopic methods, semen processing in pellets and straws, and number of frozen-thawed motile spermatozoa. Adult does (greater than or equal to 2.5 years) that had previously kidded were inseminated into the cervix, and maiden (kid: 6-8 months; hogget: 18 months) and adult does were inseminated laparoscopically. The rates of pregnancy determined by ultrasonic scanning (75-80 days after insemination) for cervical (Experiment 1) and laparoscopic (Experiments 2 and 3) insemination were 39.1%, 63.6% and 52.1%. The number of motile spermatozoa did not affect fertility after cervical (80, 120 and 160 x 10(6) or laparoscopic (Experiment 2: 15, 30 and 60 x 10(6); Experiment 3:5, 10 and 20 x 10(6) insemination. The method of insemination or number of motile spermatozoa did not affect fecundity. With cervical insemination, fertility and fecundity improved with increasing depth of insemination into the reproductive tract. Intravaginal sponges containing fluorogestone acetate and controlled internal drug release (CIDR) devices containing progesterone were equally effective for control of ovulation when combined with an injection of pregnant mare's serum gonadotrophin (PMSG; 200 i.u.) before insemination. Fertility was higher when does were inseminated before than after ovulation. After laparoscopic insemination, results were similar for semen frozen as pellets and in straws, and for 3-, 6- and 24-fold pre-freezing dilution of semen. For kid, hogget and adult does in Experiment 3, pregnancy rates were 34.0%, 55.4% and 63.9% and rates of fecundity were 1.17, 1.22 and 1.27 fetuses/pregnant doe.

Ear implants that contained 3 mg Norgestomet or vaginal pessaries that contained 40 or 45 mg fluorogestone acetate were used to induce estrus in dairy goats in three herds in May. Ear implants or vaginal pessaries were left in place for 11 d. Cloprostenol (50 mug) and PMSG (500 IU) were administered i.m. 24 h prior to removal of ear implants or vaginal pessaries. After removal of vaginal pessaries, onset of standing estrus occurred in 22 23 goats (96%) at 20 +/- 4.7 h, in 19 20 goats (95%) at 22 +/- 6.3 h, and in 16 16 goats (100%) at 19 +/- 1.2 h in Herds A, B and C, respectively. After removal of ear implants, onset of standing estrus occurred in 25 25 goats (100%) at 19 +/- 4.9 h, in 20 22 goats (91%) at 22 +/- 7.0 h, and in 15 15 goats (100%) at 18 +/- 2.2 h in Herds A, B and C, respectively. Does were bred by natural service in Herds A and B, and by artificial insemination 28 h after vaginal pessary or ear implant removal in Herd C. Pregnancy rates were determined 39 to 53 d post breeding by real-time ultrasound. Pregnancy rates in goats with vaginal pessaries were 32, 55 and 6%; and in goats with ear implants they were 56, 67 and 27% in Herds A, B and C, respectively. Problems encountered included poor libido in some bucks, abortions in undersized yearling does, and loss of ear implants by three does (not included in the data). Statistically there was no difference in pregnancy rates between goats receiving vaginal pessaries or ear implants (P>0.10).